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Background 
The Age Gap cluster randomised trial sought to test “complex” decision-support interventions 
(DESIs) consisting of an online decision tool, a brief decision aid (BDA) and a booklet for patients 
facing a treatment choice of either: 
1. surgery + endocrine therapy (ET) versus  primary endocrine therapy (PET), for frail older 
women; or,  
2. adjuvant chemotherapy or no chemotherapy for women having had surgery for high 
recurrence risk breast cancer. 
A process evaluation (PE) was undertaken to identify how the interventions worked and aid 
interpretation of the trial results. The primary aims of the PE were to understand how the DESIs 
were implemented, the barriers and facilitators, and how acceptable and useful they were to staff 
and patients. 
Methods 
Multiple methods of data collection were used: questionnaires, interviews, case report forms (CRFs) 
and audio-recording of consultations. Of 46 trial recruiting sites, 16 were PE sites.  Interviews were 
analysed using a Framework approach. Numeric data were analysed using SPSS.  
Results 
The trial included 1321 participants, 176 from PE sites were invited to participate; 77 patients 
provided data for the PE. Ten healthcare professionals (HCPs) took part in a telephone interview and 
seven in audio-recorded consultations. The online tool was used by surgeons in ways personalised to 
the patient and their own practice and, provided structure to guide treatment options. The booklets 
were introduced predominantly by nursing staff, with the BDA used as a summary sheet rather than 
to stimulate discussion as intended. The information provided encouraged more active involvement 
in decision making. Barriers to implementation were seeing the DESIs as time consuming as well as 
logistical problems e.g. access to computers. 
Discussion  
Patient and HCPs feedback on the tools was positive but utilisation was  variable both between 
centres and clinicians. Adoption was hindered by other information materials commonly provided to 
patients, time and IT constraints.   
